Literature DB >> 33752060

CISD2 plays a role in age-related diseases and cancer.

Hai-Yang Liao1, Bei Liao2, Hai-Hong Zhang3.   

Abstract

CDGSH iron-sulfur domain 2 (Cisd2) is an evolutionarily conserved protein that plays an important regulatory role in aging-related diseases and cancers. Since its discovery, Cisd2 has been identified as a regulatory factor for the aging of the human body and the regulation of mammalian lifespan. Cisd2 is also an oncoprotein that regulates the occurrence and development of cancer. Cisd2 mediates the occurrence of diseases related to human aging and the proliferation, differentiation, metastasis, and invasion of various cancer cells through various mechanisms. Multiple studies have shown that Cisd2 expression is related to the clinical characteristics of aging-related diseases and patients with cancer, and its expression profile is a novel diagnostic and prognostic biomarker for a variety of human diseases. Modulating the expression or function of Cisd2 may be a potential treatment strategy for different diseases. In this review, we summarize the role of Cisd2 in human aging-related diseases and various cancers, as well as the biological functions, underlying mechanisms, and potential clinical significance.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Age-related diseases; Biomarker; CDGSH iron-sulfur domain2 (Cisd2); Cancer; Senescence related

Year:  2021        PMID: 33752060     DOI: 10.1016/j.biopha.2021.111472

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  CDGSH iron sulfur domain 2 mitigates apoptosis, oxidative stress and inflammatory response caused by oxygen-glucose deprivation/reoxygenation in HT22 hippocampal neurons by Akt-Nrf2-activated pathway.

Authors:  Xiaoyan Ren; Jiangang Yu; Lili Guo; Zaili Zhang
Journal:  Metab Brain Dis       Date:  2022-07-12       Impact factor: 3.655

2.  High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma.

Authors:  Fang Zhang; Hua-Bao Cai; Han-Ze Liu; Shen Gao; Bin Wang; Yang-Chun Hu; Hong-Wei Cheng; Jin-Xiu Liu; Yang Gao; Wen-Ming Hong
Journal:  Dis Markers       Date:  2022-04-21       Impact factor: 3.464

Review 3.  The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.

Authors:  Priti Tagde; Pooja Tagde; Fahadul Islam; Sandeep Tagde; Muddaser Shah; Zareen Delawar Hussain; Md Habibur Rahman; Agnieszka Najda; Ibtesam S Alanazi; Mousa O Germoush; Hanan R H Mohamed; Mardi M Algandaby; Mohammed Z Nasrullah; Natalia Kot; Mohamed M Abdel-Daim
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

4.  Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.

Authors:  Tailiang Lu; Chenglong Li; Cailing Xiang; Yongqiang Gong; Wei Peng; Chaowu Chen
Journal:  Biomed Res Int       Date:  2022-03-11       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.